Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
TSE:4883
Price:
77 JPY
Updated:
Apr 30, 2024
Modalis Therapeutics Corp
Net Income (Common)
|
Modalis Therapeutics Corp
Net Income (Common) Peer Comparison
Comparables:
2160
4587
4974
J
7774
S
4599
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Modalis Therapeutics Corp
TSE:4883
|
Net Income (Common)
-¥2.4B
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Net Income (Common)
¥8.1B
|
CAGR 3-Years
86%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Net Income (Common)
¥3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Net Income (Common)
¥1.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
2%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Net Income (Common)
-¥157.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
S
|
StemRIM Inc
TSE:4599
|
Net Income (Common)
¥168.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's Net Income (Common)?
Net Income (Common)
-2.4B
JPY
-2.4B
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Net Income (Common) amounts to -2.4B JPY.
What is Modalis Therapeutics Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-61%
-61%
Over the last year, the Net Income (Common) growth was 12%. The average annual Net Income (Common) growth rates for Modalis Therapeutics Corp have been -75% over the past three years , -61% over the past five years .
You don't have any saved screeners yet
